Using Laboratory Science to Inform Clinical Decision Making and Patient Safety in Medicinal Cannabis

PDF icon CNMC BHGR 12.4.24.pdf


Learning objectives:

  1. Describe the difference in time course of THC-related drug effects between cannabis products that are inhaled versus swallowed.
  2. Be able to communicate potential risks associated with cannabis use to your patients
  3. Identify medications for which metabolism could be altered by oral CBD products
Session date: 
12/04/2024 - 11:00am to 12:00pm EST
Location: 
Virtual
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™

Please login or register to take this course.
Faculty List: 
Program Director(s)

Laura Willing, MD

has no relevant financial relationships to disclose at this time.
Speaker(s)

Ryan Vandrey, PhD

has a financial relationship (Consulting Fee) with Charlotte's Web;.
has a financial relationship (Consulting Fee) with Schedule 1 Therapeutics;.
has a financial relationship (Consulting Fee) with Syqe Medical Ltd.;.
has a financial relationship (Consulting Fee) with WebMD;.
has a financial relationship (Consulting Fee) with Jazz Pharmaceuticals;.